The direct thrombin inhibitor ximelagatran/melagatran: a systematic review on clinical applications and an evidence based assessment of risk benefit profile

Luca Testa, Ravinai Bhindi, Pierfrancesco Agostoni, Antonio Abbate, Guiseppe GL Biondi Zoccai, William J van Gaal
  • Expert Opinion on Drug Safety, July 2007, Informa Healthcare
  • DOI: 10.1517/14740338.6.4.397

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Dr Pierfrancesco Agostoni and Prof. Giuseppe Biondi-Zoccai